ABNM Nuclear Medicine study materials
ABNM Nuclear Medicine study resources

ABNM Nuclear Medicine case studies

ABNM Nuclear Medicine · Put your knowledge to work in context.

The American Board of Nuclear Medicine (ABNM) is a certifying board whose stated purpose is "Ensuring high-quality patient care by establishing standards in Nuclear Medicine." Initial certification is intended for physicians who have completed the training pathway ABNM recognizes and who wish to be examined and certified in nuclear medicine; the board separately administers continuing certification for diplomates who already hold its credential. The certification examination is a multiple-choice, computer-delivered test sampling the full breadth of the specialty. The ABNM Nuclear Medicine case studies are 5 cases and about 2,777 words.

1

The 18% Discrepancy at 07:10

At 07:10 on a Tuesday, a 58-year-old woman with papillary thyroid carcinoma is scheduled to receive 150 mCi (5.55 GBq) of I-131 for remnant ablation. The vendor certificate states 200 mCi (7.4 GBq) at 12:00 the previous day, which decays to about 170 mCi at 07:10.

627 words, about 3 min
2

68Ga-DOTATATE at 91% with a Rising Germanium Breakthrough

A 61-year-old man with a pancreatic neuroendocrine tumor is scheduled for 68Ga-DOTATATE PET/CT at 13:00. The 68Ga generator was eluted at 09:30, and the eluate was used to label a DOTATATE kit.

560 words, about 3 min
3

Nonvisualized Gallbladder After Roux-en-Y Bypass

A 54-year-old woman presents with 36 hours of right upper quadrant pain, nausea, and fever of 38.4°C. WBC is 14.8 × 10^9/L; total bilirubin 1.1 mg/dL; ALP 130 U/L; AST 55 U/L; ALT 48 U/L; lipase 30 U/L.

551 words, about 3 min
4

Interim PET Deauville 4 with Recent G-CSF

A 34-year-old man with stage II bulky diffuse large B-cell lymphoma has a baseline PET/CT showing a 12 cm mediastinal mass with SUVmax 24 and no other sites of disease. He receives two cycles of R-CHOP.

557 words, about 3 min
5

Ra-223 in a Patient with Marrow Replacement

A 72-year-old man with metastatic castration-resistant prostate cancer and bone metastases has progressed after docetaxel and enzalutamide. He is referred for Ra-223.

482 words, about 2 min